Company Filing History:
Years Active: 2015-2016
Title: Elizabeth Van Der Kam: Innovator in S1P Modulators
Introduction
Elizabeth Van Der Kam is a notable inventor based in Weesp, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of (thio)morpholine derivatives as S1P modulators. With a total of 2 patents, her work is paving the way for advancements in the treatment of S1P receptor-mediated diseases.
Latest Patents
Her latest patents focus on (thio)morpholine derivatives that exhibit affinity to S1P receptors. These compounds may be utilized in the treatment, alleviation, or prevention of various conditions associated with S1P receptor activity. The patents specifically disclose derivatives of the formula (I) or pharmaceutically acceptable salts, solvates, or hydrates thereof, while excluding certain known compounds.
Career Highlights
Elizabeth is currently employed at AbbVie Bahamas Limited, where she continues to innovate in her field. Her work is characterized by a commitment to developing new therapeutic options that can significantly impact patient care.
Collaborations
She collaborates with esteemed colleagues, including Wouter I Iwema Bakker and Hein K A C Coolen, who contribute to her research endeavors and enhance the collaborative spirit within her team.
Conclusion
Elizabeth Van Der Kam's contributions to the field of pharmaceuticals through her innovative patents highlight her role as a leading inventor in the development of S1P modulators. Her work not only showcases her expertise but also promises to improve treatment options for various diseases.